Skip to content

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Moving compounds to IND using predictive retina models


June 19, 2024

Presented by

Newcells Biotech

During this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.


  • Dr Lauren Black – Distinguished Scientist/Consultant – Charles River Laboratories
  • Dr Roxana Redis – Associate Science Director – Charles River Laboratories
  • Dr Valeria Chichagova – Director of Technology – Newcells Biotech

Watch the on demand from here

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox